With the founding of VITAIRA, Andreas Thiede and GREENPEAK Partners are jointly launching a new chapter in European pharmaceutical logistics as investors. The company’s goal is to invest in owner-managed, specialized pharmaceutical logistics service providers in order to bring them together under one umbrella and thus build a Europe-wide network for a safe and sustainable supply of medicines.
“The pharmaceutical supply chain is under significant pressure due to global supply chain risks, an aging population, and growing regulatory requirements,” explains Andreas Thiede. “With VITAIRA, we aim to strengthen European pharmaceutical production and research and offer sustainable supply solutions to healthcare providers.”
Tangible Added Value for Partners and Customers
VITAIRA pursues a clear investment strategy in:
- Pharmaceutical logistics companies specializing in GDP-compliant transportation, controlled substances, or clinical trials
- Service providers along the pharmaceutical logistics value chain, such as GMP-certified value-added services
“As part of the group, partner companies benefit from shared infrastructure, regulatory expertise, and a European network. Our partners retain their entrepreneurial independence and identity while ensuring the long-term sustainability of their life’s work. Customers—ranging from pharmaceutical manufacturers to clinics and pharmacies—thus gain planning certainty through reliable, flexible, and future-proof logistics solutions that meet the highest quality and safety standards,” emphasizes Thiede.
A Strong Partner for Long-Term Growth
With GREENPEAK Partners, VITAIRA has an experienced, long-term “buy-and-build” investor at its side that has successfully built market-leading corporate groups in B2B service segments since 2015.
About Andreas Thiede
The 55-year-old has more than two decades of experience in leadership roles in the healthcare sector. As CEO of the pharmaceutical wholesaler GEHE and as Managing Director at Fiege Healthcare Logistics, he has played a key role in shaping the industry’s structure. Through VITAIRA, he is now bringing his experience and network to bear to establish, together with strong partners, a new corporate group in the European pharmaceutical logistics sector.